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Abstract 
Common cold is one of the most frequent human inflammatory diseases caused by viruses 
and can facilitate bacterial super-infections resulting in sinusitis or pneumonia. The active 
ingredient of the drug Soledum, 1,8-cineole, is commonly applied for treating inflammatory 
diseases of the respiratory tract. However, the potential of 1,8-cineole for treating primary 
viral infections of the respiratory tract remains unclear. 
In the present study, we demonstrate for the first time that 1,8-cineole potentiates Poly(I:C)-
induced activity of the anti-viral transcription factor Interferon Regulatory Factor 3, while 
simultaneously reducing pro-inflammatory NF-κB-activity in human cell lines, inferior 
turbinate stem cells (ITSCs) and ex vivo cultivated human nasal mucosa. Co-treatment of 
cell lines with Poly(I:C) and 1,8-cineole resulted in significantly increased IRF3 reporter gene 
activity compared to Poly(I:C) alone, whereas NF-κB-activity was reduced. Accordingly, 1,8-
cineole- and Poly(I:C)-treatment led to increased nuclear translocation of IRF3 in ITSCs and 
a human ex vivo model of rhinosinusitis compared to the Poly(I:C)-treated approach. Nuclear 
translocation of IRF3 was significantly increased in ITSCs and slice cultures treated with LPS 
and 1,8-cineole compared to the LPS-treated cells mimicking bacterial infection.  
Our findings strongly suggest that 1,8-cineole potentiates the antiviral activity of IRF3 in 
addition to its inhibitory effect on pro-inflammatory NF-κB-signalling and may thus broaden its 
field of application. 
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Summary statement  
Respiratory diseases are highly frequent and can be treated with 1,8-cineole. We show that 
1,8-cineole potentiates antiviral activity in cultivated human nasal stem cells, and nasal 
tissue. The combination with its anti-inflammatory effect suggests new treatment strategies 
against common cold.  
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Introduction 
The common cold syndrome is one of the most frequent inflammatory diseases, averagely 
affecting an adult two to four times per year (reviewed in (1)). Infection of the respiratory tract 
by rhinoviruses (2), or to a lesser extent by coronaviruses or influenza viruses is followed by 
typical symptoms ranging from sneezing, sore throat, cough and nasal congestion to 
tiredness and malaise (3, 4). In addition, common cold has been reported to lead to an 
increase of acute exacerbations in patients with asthma and chronic obstructive pulmonary 
disease (COPD) (5-7). The damage of respiratory epithelium during viral infection further 
facilitates bacterial infections of the respiratory tract and subsequent inflammatory diseases 
like sinusitis and pneumonia (reviewed in (1)). 
Natural, plant-derived monoterpenoids are commonly applied for treatment of inflammatory 
diseases of the respiratory tract (8). Initially identified by Cloez in 1870 as the dominant 
portion of Eucalyptus globulus oil (9), the monoterpenoid 1,8-cineole was described to have 
an anti-bacterial activity (10, 11) as well as anti-inflammatory effects in animal models of 
allergic airway inflammation (12, 13) and acute pulmonary inflammation (14). 1,8-cineole is 
currently therapeutically applied as the active ingredient of the drug Soledum. Placebo-
controlled, double blind trials demonstrated an effective treatment of acute sinusitis with 1,8-
cineole in 152 patients (15). Worth and colleagues further demonstrated 1,8-cineole to 
improve lung function and reduce exacerbations in 242 patients suffering from COPD (16). 
Likewise, Juergens et al. showed beneficial effects of 1,8-cineole in 12 of 16 patients with 
bronchial asthma (17, 18). Indicating a potential molecular mechanism by cytokine inhibition, 
1,8-cineole reduced the production of pro-inflammatory cytokines TNFα and IL1β in human 
monocytes (19). We extended these findings by demonstrating that 1,8-cineole inhibits the 
activity of the transcription factor nuclear factor kappa light chain enhancer of activated B-
cells (NF-κB), a key mediator of pro-inflammatory signalling. In particular, we showed a 1,8-
cineole-dependent reduction of nuclear translocation of NF-κB p65 and decreased NF-κB-
dependent transcriptional activity (20). This novel mode of action was recently confirmed by 
Zhao and co-workers, who showed a NF-κB-associated reduction of pro-inflammatory 
cytokines after 1,8-cineole-treatment in the mouse system in vivo (14). Despite these 
promising effects against bacteria-induced inflammation, the potential effect of 1,8-cineole for 
treating the predisposing viral infection remains unclear. In the present study, we applied the 
double-stranded RNA analogue Poly(I:C) (polyinosinic:polycytidylic acid) to mimic viral 
infection in vitro and ex vivo. Poly(I:C) is broadly described to induce antiviral responses in a 
broad variety of cell types such as human alveolar, corneal and bronchial epithelial cells (21, 
22) as well as in the lung of mice (23). Poly(I:C) is recognized by Toll-like receptor 3 (TLR3), 
in turn leading to a cellular antiviral response via activation of the MyD88-independent 
signalling pathway culminating in activation of IRF3 and production of type I interferons (IFN). 
In addition to activation of IRF3, MyD88-independent signalling results in a late and weak 
activation of NF-κB followed by a moderate release of pro-inflammatory cytokines (24, 25). 
Notably, Wang et al. reported in 2009 a TLR3-mediated recognition of rhinoviral dsRNA 
intermediates in rhinovirus-infected airway epithelial cells (26), highlighting the suitability of 
Poly(I:C) to mimic rhinoviral infection. In the present study, we determined potential effects of 
1,8-cineole on antiviral IRF3-activity using human cell lines and human nasal stem cells 
isolated from the inferior turbinate. ITSCs represent a promising cellular model system due to 
their easy expandability and their endogenous niche within the respiratory epithelium (27, 
28).  Next to cellular models, we described very recently the successful application of ex vivo 
cultivated human nasal slices from the inferior turbinate as a novel model system of the late 
phase of rhinosinusitis. Here, treatment with 1,8-cineole significantly reduced the amount of 
Alcian Blue-stained mucin within goblet cells. Accordingly, we observed a significant 
reduction of MUC2 gene expression in ex vivo cultivated nasal slices accompanied by 
attenuated expression levels of TNFα (29). In the present study, we demonstrate for the first 
time that 1,8-cineole leads to elevated levels of antiviral IRF3-activity in human cell lines, 
ITSCs as well as in ex vivo cultivated human nasal tissue in a viral mimic model. In 
particular, Poly(I:C)-treatment of human cell lines resulted in increased activity, nuclear 
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translocation and respective target gene expression of IRF3 and NF-κB. Exposure to 
Poly(I:C) and 1,8-cineole led to significantly increased IRF3-activity, accompanied by 
reduced nuclear translocation of NF-κB p65 and diminished NF-κB-activity. Notably, nuclear 
translocation of IRF3 was significantly increased in ITSCs and nasal slice cultures treated 
with Poly(I:C) and 1,8-cineole in comparison to the Poly(I:C)-treated approaches. Moreover, 
LPS-treatment of human nasal slice cultures led to an increased activity of IRF3, which was 
further significantly increased after co-treatment with 1,8-cineole. 
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Materials and Methods 
Cell culture 
Human cell lines U373 and U251 were cultivated in DMEM High Glucose (Sigma-Aldrich, 
cat. No. D5671, Taufkirchen, Germany) containing 1% L-Glu (200 mM; Sigma-Aldrich, 
Taufkirchen, Germany) and 10 % fetal calf serum (FCS, lot: 126K3398, Sigma-Aldrich, 
Taufkirchen, Germany) in a humidified incubator (Binder, Tuttlingen, Germany) at 37 °C and 
5 % CO2. ITSCs were isolated from inferior turbinates obtained during nasal surgery after an 
informed consent according to local and international guidelines (Bezirksregierung Detmold/ 
Münster). Isolation and further experimental procedures were ethically approved by the 
ethics commission of the Ärztekammer Westfalen-Lippe and the medical faculty of the 
Westfälische Wilhems-Universität (Münster, Germany) (approval reference number 2012-15-
fS). Isolation and cultivation procedures were performed as described in Hauser et al. (27). 
U373 and U251 cells as well as ITSCs were treated with Poly(I:C) (polyinosinic-polycytidylic 
acid sodium salt, 100 µg/ml, cat. No. P1530, Sigma Aldrich), LPS (Lipopolysaccharides, 1 
μg/ml, rough strains from Salmonella enterica Re 595, cat. no. L9764, Sigma-Adrich St. 
Louis, MO, USA), or LPS/Poly(I:C) and 1,8-cineole (10-4 M, prepared as described in Greiner 
et al (20), Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, 
Germany). 
Tissue culture of nasal turbinate slices 
Human nasal inferior turbinates were isolated during nasal surgery after an informed consent 
according to local and international guidelines (Bezirksregierung Detmold/ Münster). Isolation 
and further experimental procedures were ethically approved by the ethics commission of the 
Ärztekammer Westfalen-Lippe and the medical faculty of the Westfälische Wilhems-
Universität (Münster, Germany) (approval reference number 2012-15-fS). Sliced Inferior 
turbinate tissue (200µm thickness) was transferred to culture plate inserts (0.4 µm 
nitrocellulose membrane, Millipore/Greiner, Billerica, MA, USA) and cultivated at the interface 
of air and B-ALI differentiation medium (Lonza, Basel, Switzerland) as previously described 
(29). Nasal slices were cultured for at least one week followed by treatment with LPS (100 
ng/ml, rough strains from Salmonella enterica Re 595, cat. no. L9764, Sigma-Adrich St. 
Louis, MO, USA), or co-treatment with LPS and 1,8-cineole (10-4 M, Klosterfrau Healthcare 
Group, Cassella-med GmbH & Co. KG, Cologne, Germany) for 24 h followed by 
immunohistochemistry as described below. Treatment of nasal slice cultures with Poly(I:C)- 
(100 µg/ml, Sigma Aldrich) or Poly(I:C) and 1,8-cineole (10-4 M, Klosterfrau Healthcare 
Group, Cassella-med GmbH & Co. KG)  was performed for 2 h and 4 h followed by 
immunohistochemistry as described below.  
Transient transfection and gene reporter assays 
U373 and U251 cells were transfected with 2.2 µg pRL-CMV (Promega Cooperation, 
Mannheim, Germany) and 1.1 µg TK (NF-κB)6 LUC (30) for NF-κB reporter gene assays or 
2.2 µg pRL-CMV (Promega Cooperation, Mannheim, Germany) as well as 1µg IRF3-Gal4 
and 1µg UAS-LUC (kindly provided by Katherine A. Fitzgerald, Department of Medicine, 
University of Massachusetts Medical School, Worcester, USA). Transfection was performed 
using rat NSC Nucleofector Kit (Amaxa Biosystems, Lonza Group AG, Basel, Switzerland) 
and Nucleofector II device (Lonza Group) according to manufacturer’s guidelines. FPred (1.5 
µg, Lonza Group, Basel, Switzerland) or pmaxGFP (0.3 µg, Lonza Group, Basel, 
Switzerland) served as transfection control. 24 h after transfection, U373 and U251 cells 
were treated with Poly(I:C) (Sigma Aldrich), LPS (1 μg/ml, rough strains from Salmonella 
enterica Re 595, Sigma-Adrich), or combinations of LPS/Poly(I:C) and 1,8-cineole (1x10-4 M 
or 2x10-4 M prepared as described in Greiner et al (20), Klosterfrau Healthcare Group) for 24 
h. Luciferase activity was subsequently assessed by applying Dual-Luciferase® Reporter 
Assay System (Promega Corporation, cat. no. E1960) according to manufacturer’s 
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guidelines. Statistical analysis was performed using GraphPad Prism software (GraphPad 
Software, La Jolla, CA, USA), bioluminescence of constitutively active Renilla luciferase 
(pRL-CMV vector) served for normalization. 
Reverse transcription PCR 
Total RNA was isolated from untreated and Poly(I:C)-treated U251 cells , and peripheral 
blood monocytes (PBMCs) as described above using RNeasy Mini Kit (QIAGEN, Hilden, 
Germany) according to manufacturer’s guidelines or via phenol-chloroform extraction. 
PBMCs (no. 090928AUK136/02) were kindly provided by Cellular Therapy Centre, Medical 
School Hannover, Hannover, Germany (informed consent was provided to Klinikum 
Bielefeld, Bielefeld, Germany). Quality and concentration of RNA was determined using 
Nanodrop UV spectrophotometry followed by cDNA synthesis via application of First Strand 
cDNA Synthesis Kit (Thermo Fisher Scientific, cat. No. K1612, Darmstadt, Germany) 
according to manufacturer’s guidelines. PCR was performed using GoTaq Polymerase 
(Promega Cooperation, Mannheim, Germany) according to manufacturer’s guidelines. For 
primer sequences (0.5 µM, Metabion, Martinsried, Germany) see Table 1. 
Real Time PCR 
Total RNA was isolated from ITSCs treated as described above using RNeasy Mini Kit 
(QIAGEN, Hilden, Germany) followed by cDNA synthesis with qSqript cDNA Synthesis Kit 
(Quanta, Gaithersburg, MD, USA) according to manufacturer’s guidelines. All qPCR 
reactions were performed as triplicate using 5x EvaGreen® QPCR-Mix II (Bio-Budget 
Technologies GmbH, Krefeld, Germany) according to manufacturer’s guidelines and assayed 
with a Rotor Gene 6000 (QIAGEN). Primer sequences (0.5 µM, Metabion, Martinsried, 
Germany) were CCCTCGCTGTCATCCTCATT (RANTES forward), 
ACGACTGCTGGGTTGGAG (RANTES reverse), CTGCACCACCAACTGCTTAG (GAPDH 
forward) and GTCTTCTGGGTGGCAGTGAT (GAPDH reverse). 
Immunocytochemistry 
For immunocytochemistry, U251 cells, U373 cells, and ITSCs treated as described above 
were fixed using 4 % paraformaldehyde (PFA, 4 % paraformaldehyde, 100 mM NaH2PO4, 
0.4 mM CaCl2) for 20 minutes followed by permeabilization and blocking with 0.02 % PBT 
(0.02 % TritonX-100 (Sigma-Aldrich cat. No. T8787, Taufkirchen, Germany) in PBS) 
comprising 5 % goat serum (Dianova, Hamburg, Germany). Primary antibodies anti-NF-κB-
p65 (sc-372 or sc8008, Santa Cruz Biotechnologies) or anti-IRF3 (sc-9082, Santa Cruz 
Biotechnologies) were applied for 1 h.  Respective secondary fluorochrome-conjugated 
antibodies (A21428, A21422, A21201, Molecular Probes, Göttingen, Germany) were 
subsequently added for 1 h under exclusion of light. Nuclear counterstaining was performed 
by applying 4′,6-Diamidin-2-phenylindol (DAPI; 1:2000, Life Technologies, Darmstadt, 
Germany) for 15 min followed by covering with mowiol. Fluorescence imaging was done 
using confocal scanning microscopy (LSM 780, Carl Zeiss, Jena, Germany) and ZEN 
software (Carl Zeiss). Image processing and analysis were performed using Fiji (31) followed 
by statistical analysis with GraphPad Prism software (GraphPad Software, La Jolla, CA, 
USA). 
Immunohistochemistry 
Nasal slices cultivated and treated as described above were removed from the culture inserts 
followed by preparation of 10 µm thick cryosections. For immunohistochemistry, 4 % PFA 
was applied for 20 minutes followed by permeabilization and blocking with 0.1 % PBT 
(Sigma-Aldrich) comprising 5 % goat serum (Dianova) and addition of primary antibodies 
anti-NF-κB-p65 (sc-372 or sc8008, Santa Cruz Biotechnologies), anti-IRF3 (sc-9082, Santa 
Cruz Biotechnologies) or anti-CK14 (sc-7156, Santa Cruz Biotechnologies) for 2 h. 
Respective secondary fluorochrome-conjugated antibodies (A21428, A21422, A21201, 
Molecular Probes) were subsequently applied for 1 h under exclusion of light. Nuclear 
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counterstaining was done using DAPI (1:2000, Life Technologies) for 15 min followed by 
covering with mowiol. Fluorescence imaging was done via confocal scanning microscopy 
(LSM 780, Carl Zeiss) and ZEN software (Carl Zeiss) followed by image processing and 
analysis using Fiji (31). Statistical analysis was performed using GraphPad Prism software 
(GraphPad Software). 
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Results  
Poly(I:C)-driven mimicry of viral infection increases activity of NF-κB and IRF3 
Assessing the presence of protein transcripts relevant for NF-κB- and IRF3-signalling in 
U251 cells, we showed expression of Toll-like receptor 3 and 4 (TLR3, TLR4), cluster of 
differentiation 14 (CD14), Lymphocyte antigen 96 (MD2), Myeloid differentiation primary 
response gene 88 (MYD88), TIR-domain-containing adapter-inducing interferon-β (TRIF), 
Toll/interleukin-1 receptor domain-containing adapter protein (TIRAP) and TRIF related 
adapter molecule (TRAM) (Fig. 1A). In order to mimic viral infection in U251 cells, we applied 
the double strand RNA analogue Poly(I:C) to simulate the presence of dsRNA replication 
intermediates of single strand RNA viruses (24, 26). U251 cells transiently transfected with a 
dual luciferase NF-κB-reporter system showed a significant increase in luciferase activity 
after treatment with increasing concentrations of Poly(I:C) (25 - 1000 µg / ml) in comparison 
to untreated control. In addition, we observed significantly augmented luciferase activities 
compared to control in response to Poly(I:C) (25 - 1000 µg / ml) in U251 cells transiently 
transfected with a IRF3-driven luciferase reporter system (Fig. 1B). 
Significantly increased nuclear translocation of IRF3 and NF-κB p65 after Poly(I:C)-
treatment is accompanied by an increased expression of IRF3 and  NF-κB target genes  
Validating the increase in sustained IRF3- and NF-κB-activity, we showed an augmented 
nuclear translocation of IRF3 and NF-κB p65 in U251 cells after Poly(I:C)-treatment 
compared to the control (Fig. 1C, Fig. S1, Fig. S2). Quantification of immunocytochemical 
stainings confirmed the increase in the amount of nuclear IRF3 after 2 h and 4 h of Poly(I:C)-
treatment. Accordingly, significantly elevated nuclear translocation of NF-κB p65 was 
observed in U251 cells treated with Poly(I:C) for 2 h in comparison to control (Fig. 1D). RT-
PCR analysis further demonstrated increased expression of IRF3 target genes Regulated on 
Activation, Normal T cell Expressed and Secreted (RANTES) and interferon- β (IFN-β). In 
addition, we detected an elevated expression of the NF-κB target gene tumour necrosis 
factor α (TNFα) in Poly(I:C)-treated U251 cells compared to untreated control (Fig. 1E). 
Poly(I:C)-induced activity of IRF3 is further increased by co-treatment with 1,8-cineole 
To investigate potential effects of 1,8-cineole on IRF3 after Poly(I:C)-mediated simulation of 
viral infection we transiently transfected U373 cells with a dual IRF3 luciferase reporter 
system. Poly(I:C)-treatment of U373 cells transiently transfected with the dual IRF3-reporter 
system led to significantly increased luciferase activity in comparison to control. Although we 
observed no effects of 1,8-cineole alone (Fig. S3A), combination of Poly(I:C) and 1,8-cineole 
led to a further increase of luciferase activity if compared to Poly(I:C)-treated cells (Fig. 2A). 
1,8-cineole leads to strongly reduced nuclear translocation of NF-κB p65 as well as 
significantly reduced levels of NF-κB-activity after Poly(I:C)-treatment 
Next, we determined the effects of 1,8-cineole on NF-κB after Poly(I:C) stimulation. 
Luciferase activity in U251 cells transiently transfected with a dual NF-κB-reporter system 
showed an increase of NF-κB-activity after Poly(I:C)-treatment in comparison to control. Co-
treatment with 1,8-cineole resulted in significantly decreased luciferase activity compared to 
Poly(I:C)-treated cells (Fig. 2A), demonstrating the reduction of pro-inflammatory NF-κB-
activity by 1,8-cineole in a model of viral infection. Treatment of U373 cells with Poly(I:C) 
similarly resulted in increased nuclear translocation of NF-κB p65 compared to the untreated 
control. Moreover, we observed a significantly decreased nuclear localization of NF-κB p65 
after exposure of U373 cells to Poly(I:C) and 1,8-cineole in comparison to Poly(I:C)-
stimulated cells (Fig. 2C-D). No differences to control were observed in cell treated with 1,8-
cineole alone (Fig. S3B). 
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1,8-cineole-treatment results in significantly augmented IRF3-activity and reduced 
activity of NF-κB p65 after LPS-stimulation 
In order to investigate the activity of IRF3 after LPS-treatment, U373 cells were transiently 
transfected with a dual IRF3-reporter system. Here, we detected significantly higher 
luciferase bioluminescence after LPS-treatment compared to untreated control. U373 cells 
co-treated with LPS and 1,8-cineole showed a further increase in IRF3-activity in comparison 
to cells treated with LPS alone (Fig. 2B). 
A dual luciferase reporter gene assay revealed significantly increased NF-κB-activity after 
treatment with LPS in comparison to control. Co-treatment with 1,8-cineole resulted in a 
significant decrease in luciferase activity compared to the cells exposed to LPS alone (Fig. 
2B). In accordance with our previous findings (20), we observed significantly reduced 
amounts of nuclear NF-κB p65 after treatment with 1,8-cineole and LPS compared to LPS-
stimulation alone (data not shown).  
Poly(I:C) leads to increased nuclear translocation of IRF3 and NF-κB in ITSCs 
With regards to the endogenous environment of rhinosinusitis, we applied stem cells isolated 
from the respiratory epithelium of adult human inferior turbinate (Fig. 3A-B) to further 
determine potential effects of 1,8-cineole on the activity of IRF3 and NF-κB. Validating the 
suitability of ITSCs to investigate Poly(I:C)- and LPS-induced activation of IRF3 and NF-κB, 
we showed expression of TLR3 and TLR4 in ITSCs isolated from three independent donors 
(Fig. 3C). Exposure of ITSCs to Poly(I:C) for 2 h resulted in significantly increased nuclear 
translocation of IRF3 accompanied by highly elevated amounts of nuclear localized NF-κB 
p65 in comparison to control (Fig 3D-F). 
Co-treatment of ITSCs with Poly(I:C) and 1,8-cineole results in increased IRF3-activity 
accompanied by significantly reduced activity of NF-κB 
ITSCs were co-treated with 1,8-cineole and Poly(I:C) as described above and subjected to 
immunocytochemical analysis of nuclear IRF3 and p65. Here, co-treatment of ITSCs with 
Poly(I:C) and 1,8-cineole led to significantly increased nuclear translocation of IRF3 in 
comparison to Poly(I:C)-stimulation (Fig. 3D-E). However, a significant decrease in the 
amount of nuclear localized NF-κB p65 was observed in ITSCs exposed to Poly(I:C) and 1,8-
cineole compared to Poly(I:C)-treated cells (Fig. 3D,3F). 
1,8-cineole leads to significantly decreased nuclear localization of NF-κB p65 in LPS-
treated ITSCs 
ITSCs were exposed to LPS to mimic bacterial infection common during late rhinosinusitis. 
LPS-treatment of ITSCs for 2 h led to an increased nuclear translocation of NF-κB p65 
compared to control (Fig. 4A). Co-treatment with 1,8-cineole resulted in a significant 
decrease of nuclear NF-κB p65 in comparison to Poly(I:C)-stimulation (Fig. 4B). Notably, we 
observed no changes of nuclear translocation of IRF3 and NF-κB after treatment with 1,8-
cineole alone (Fig. S3C). 
Expression of the IRF3-target gene RANTES is elevated in ITSCs after treatment with 
1,8-cineole in a model of superinfection 
As a model of superinfection, ITSCs were pre-treated with Poly(I:C) for 4 h followed by co-
exposure to Poly(I:C) and LPS for 20 h. In comparison to control, significantly increased 
expression levels of the IRF3 target gene RANTES were observed after simulation of 
superinfection (Fig. 4C). Co-treatment of ITSCs with Poly(I:C), LPS and 1,8-cineole led to 
further increase in RANTES expression compared to Poly(I:C)/LPS- stimulation (Fig. 4C). 
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1,8-cineole leads to increased nuclear IRF3 and decreased nuclear translocation of 
NF-κB p65 in ex vivo human nasal turbinate slices stimulated with Poly(I:C) 
We investigated potential effects of 1,8-cineole on IRF3-activity in ex vivo cultivated human 
nasal turbinate tissue treated with Poly(I:C). Cultured nasal turbinate tissue remained an 
intact epithelial layer demonstrated by expression of CK14 at protein level (Fig. S3A). After 2 
h of Poly(I:C)-treatment, turbinate tissue revealed slightly increased amounts of nuclear 
IRF3, which were further elevated after co-treatment with 1,8-cineole (Fig 5A). Quantification 
of nuclear fluorescence intensities in the immunohistochemical stainings revealed a 
statistically significant increase in nuclear translocation of IRF3 after co-treatment of nasal 
slice cultures with Poly(I:C) and 1,8-cineole in comparison to control and Poly(I:C)-treated 
human nasal slices (Fig. 5B). In contrast to the fast kinetics of Poly(I:C)-dependent activation 
of IRF3 observed in ITSCs (2 h, Fig. 3D-E), Poly(I:C)-treatment of ex vivo cultivated human 
nasal slices resulted in a delayed, but significantly increased nuclear translocation of IRF3 
after 4 h (Fig 5C). In addition, we observed further increased amounts of nuclear localized 
IRF3 after co-treatment with Poly(I:C) and 1,8-cineole compared to Poly(I:C)-treated slices 
(Fig 5C). Statistically significant increase in nuclear IRF3 was observed after co-treatment of 
nasal slice cultures with Poly(I:C) and 1,8-cineole in comparison to control (Fig. 5D). 
Besides the increased activity of IRF3, we observed significantly increased nuclear 
translocation of NF-κB in Poly(I:C)-treated nasal slice cultures compared to control after 2 h 
(Fig. 6). Co-treatment with 1,8-cineole and Poly(I:C) for 2 h resulted in significantly 
decreased nuclear NF-κB compared to slices treated with Poly(I:C) alone (Fig. 6). 
Co-treatment of nasal slice cultures with 1,8-cineole and LPS leads to nuclear 
translocation of IRF3 and decrease of nuclear NF-κB 
In a model of late rhinosinusitis, nasal slice cultures were treated with LPS followed by 
analysis via immunohistochemistry. We observed an increase in nuclear IRF3 after exposure 
to LPS, and a further increase in nasal slices co-treated with 1,8-cineole (Fig. 7A, middle 
panels). LPS-treatment resulted in an increased nuclear translocation of NF-κB in human 
nasal slice cultures, which was highly decreased after co-treatment with 1,8-cineole (Fig. 7A, 
right panels, Fig. S4A). We quantified the nuclear fluorescence intensities in the 
immunohistochemical stainings and showed a statistically significant increase in nuclear 
translocation of IRF3 after co-treatment of nasal slice cultures with LPS and 1,8-cineole in 
comparison to control (Fig. 7B). The amount of nuclear NF-κB after LPS stimulation was 
significantly decreased after co-treatment with 1,8-cineole (Fig. 7C, Fig. S4B-C). 
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Discussion 
Model systems of airway diseases include cellular models, such as primary cultures and cell 
lines of human tracheal or nasal epithelium. In an alveolar epithelial cell line and a bronchial 
epithelial cell line treated with double-stranded RNA and influenza A virus Guillot and co-
workers showed immune response via secretion of the cytokines IL-8, RANTES and IFN-β 
(21). Moreover, primary cell cultures of human tracheal or nasal epithelium infected with 
rhinoviruses further revealed increased levels of viral RNA and a release of infectious 
particles (32). In the present study, ITSCs were successfully applied as a novel stem cell 
model of airway diseases. Next to their great potential for regenerative medicine (33), ITSCs 
are easily expandable and remain their genetic stability during cultivation (28). Notably, these 
cells are endogenously located within the respiratory epithelium of the human inferior 
turbinate (27), further emphasizing their applicability for pharmacological research of the 
upper respiratory tract. Next to these promising cellular model systems, mouse models are 
broadly used to simulate airway diseases in vivo (34), although potential differences in the 
upstream signalling of the antiviral response may question the transferability to the human 
system (35). Facing this challenge, organ slice cultures remain promising alternatives in 
terms of resembling the endogenous niche. Here, Switalla and colleagues showed normal 
innate cytokine response to immunomodulators in human precision-cut lung slices (36). 
Likewise, increased immune responses were observed in human lung slices infected with 
influenza virus (37), enabling the application of the model system to functionally test 
inhalable nanoparticle based influenza vaccine (38). Primary human nasal tissue cultures 
applied in the present study closely resemble the complex architecture of the endogenous 
niche including an intact ciliated epithelial surface comprising acetyl-α-tubulin-positive cilia, a 
basal membrane and mucus-filled goblet cells (29). Arruda et al. showed replication of 
human rhinovirus to occur in the upper respiratory tract, in particular within the nasal 
epithelium and the nasopharynx (39), underlining the suitability of the here applied stem cell 
and tissue model systems for mimicking rhinoviral infection. 
To simulate rhinoviral infection in ex vivo cultivated human nasal tissue as well as human 
stem cells and cell lines, Poly(I:C) was applied. This dsRNA analogue is described to 
mediate antiviral responses in a broad range of cell types (21-23) as well as in the mouse 
system after intraperitoneal administration (40). On molecular level, both rhinoviral dsRNA 
intermediates and Poly(I:C) are recognized via TLR3, which in turn leads to activation of the 
MyD88-independent signalling pathway resulting in recruitment of TRIF (TIR-domain-
containing adapter-inducing interferon-β) and activation of IRF3. Active IRF3-dimers 
translocate into the nucleus and regulate the expression of IFN-β and RANTES, thereby 
mediating the cellular antiviral response (25). In addition to mediation of the IRF3-activation, 
TRIF is also able to activate a late and weak NF-κB response through TRAF6. Activation of 
NF-κB is followed by expression of its target genes including the pro-inflammatory cytokine 
TNFα. Accordingly, we observed an increase in antiviral IRF3- and pro-inflammatory NF-κB-
activity accompanied by elevated expression of IFN-β,  RANTES and TNFα after Poly(I:C)-
treatment. Co-treatment with Poly(I:C) and 1,8-cineole led to significantly increased IRF3-
activity, whereas NF-κB-activity was significantly reduced in comparison to Poly(I:C)-treated 
cells. 
These findings are in general accordance with other studies, hence terpenoids are known to 
possess direct antiviral properties (reviewed in (41)). In particular, α-terpinene, γ-terpinene, 
α-pinene and also 1,8-cineole were shown to have an antiviral activity against the DNA virus 
herpes simplex virus type 1 (HSV-1) by directly inactivating free virus particles (42). Chiang 
and co-workers further described a broad range of antiviral activity of the terpenoid alcohol 
linalool and the triterpenoid ursolic acid, namely against adenoviruses, hepatitis B virus, 
coxsackievirus B1 and enterovirus 71 (43).  
Next to mimicking viral infection, we applied LPS to simulate secondary bacterial infection 
common during late rhinosinusitis (44). Consistent with our previous findings (20, 29) and the 
broadly described anti-inflammatory activity of monoterpenoids (reviewed in (45)), LPS-
13 
 
treatment led to significantly increased NF-κB-activity, which was significantly decreased 
after co-treatment with 1,8-cineole. Likewise to Poly(I:C)-mediated MyD88-independent 
signalling, IRF3 can be activated by LPS in a TRIF-dependent manner. Here, recognition of 
LPS by the Toll-like receptor 4 (TLR4) is followed by recruitment of TRIF, in turn leading to 
nuclear translocation of IRF3 and expression of respective target genes (46). In the present 
study, we observed an increased nuclear translocation of IRF3 in human nasal slice cultures 
after LPS-stimulation. Co-treatment with 1,8-cineole significantly increased the amount of 
nuclear IRF3, suggesting an antiviral activity of 1,8-cineole during late rhinosinusitis. 
Moreover, 1,8-cineole led to significantly elevated expression levels of the IRF-3 target gene 
RANTES in Poly(I:C)-pre-treated ITSCs after additional co-treatment with LPS and Poly(I:C) 
mimicking bacterial superinfection. 
The potential therapeutic impact of activating IRF3-mediated antiviral responses while 
simultaneously inhibiting pro-inflammatory NF-κB-signalling was impressively shown by 
Bartlett and coworkers. In particular, the authors demonstrated reduced inflammation but 
unchanged antiviral responses in vivo in rhinovirus-infected mice lacking NF-κB-p65. 
However, Interferon α-receptor 1-deficient mice infected with rhinoviruses showed elevated 
levels of rhinovirus replication and decreased antiviral responses, suggesting a new 
therapeutic strategy against rhinoviral infection via reduction of NF-κB-dependent pro-
inflammatory signalling accompanied by increased antiviral IFN-signalling (47). Next to 
common cold syndromes, rhinovirus infections also increase acute exacerbations in asthma 
patients (6). Rhinovirus-induced asthma is often accompanied by glucocorticoid resistance in 
an NF-κB-dependent manner, resulting in inefficient treatment of asthma exacerbations (48). 
Since 1,8-cineole is already established for treating steroid-dependent asthma (17), the here 
observed IRF3-dependent anti-viral activity of 1,8-cineole in addition to the already described 
inhibitory effects on NF-κB-signalling (20) may further broaden its range of application. 
In summary, this study demonstrates for the first time that 1,8-cineole, which is clinically 
approved as the active ingredient of Soledum, activates IRF3-mediated antiviral response in 
a human ex vivo model of rhinosinusitis. Our findings may broaden the range of clinical 
applications of 1,8-cineole, particularly in terms of treating the common cold syndrome and 
related ssRNA virus-dependent airway infections. 
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Clinical perspectives  
 
 
Although the common cold syndrome is one of the most frequent virally caused human 
diseases and can facilitate severe secondary infections like sinusitis or pneumonia, treatment 
strategies often do not target the underlying viral infection. 
 
Applying ex vivo cultivated human nasal tissue as a model system of rhinosinusitis, we 
demonstrate here that 1,8-cineole, the active ingredient of the drug Soledum, potentiates the 
antiviral activity of IRF3 in addition to its inhibitory effect on pro-inflammatory NF-κB-
signalling. 
 
The antiviral activity of 1,8-cineole shown in the present study may broaden its range of 
applications particularly in terms of treating the common cold syndrome and related 
rhinovirus-dependent airway infections. 
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Figure 1. Double strand RNA analogue Poly(I:C) leads to increased activity of NF-κB and 
IRF3. (A) RT-PCR revealed expression of transcripts encoding proteins involved in NF-κB-
and IRF3 signalling in U251 cells. (B) Poly(I:C)-treatment resulted in significantly increased 
luciferase activities in U251 cells transiently transfected with TK(NF-κB)6LUC and pRL-CMV 
vector or IRF3-GAL4, UAS-LUC and pRL-CMV vectors in comparison to untreated control. 
(***p<0.001 was considered significant; unpaired t-test, two tailed, confidence interval: 95%.) 
(C-D) Quantification of fluorescence intensities of immunocytochemical staining (displayed 
as intensity scale) depicting significantly increased nuclear localization of NF-κB p65 and 
IRF3 in U251 cells after Poly(I:C)-treatment compared to untreated controls (data merged of 
three independent measurement, ***p<0.001 was considered significant). (E) RT-PCR 
showing increased expression levels of the NF-κB target gene TNFα as well as IRF3 target 
genes RANTES and IFN-β after exposure to Poly(I:C) in comparison to untreated control. 
NTC: no template control. 
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Figure 2. 1,8-cineole leads to increased IRF3-activity and reduced activity of NF-κB in U373 
cells stimulated with Poly(I:C) or LPS. (A) Luciferase activity in U373 cells transiently 
transfected with IRF3-driven luciferase reporters was significantly increased after treatment 
with Poly(I:C) in comparison to untreated control. Co-treatment with Poly(I:C) and 1,8-cineole 
resulted in significantly increased luciferase activity when compared to the Poly(I:C)-treated 
approach. Significantly increased luciferase activity in U373 cells transiently transfected with 
NF-κB-dependent luciferase reporters after exposure to Poly(I:C) was significantly decreased 
after co-treatment with 1,8-cineole. (***p<0.001, **p<0.01 and *p<0.05 was considered 
significant, unpaired t-test, two tailed, confidence interval: 95%. Data merged from two 
independent measurements.) (B) Treatment with LPS resulted in significantly increased 
luciferase activity in U373 cells transiently transfected with IRF3-luciferase reporters 
compared to untreated control. Co-treatment with LPS and 1,8-cineole resulted in 
significantly increased amounts of luciferase activity compared to the LPS-treated cells. 
U373 cells transiently transfected with NF-κB-driven luciferase reporters showed significantly 
increased luciferase activity after LPS-treatment, which was significantly decreased after co-
treatment with 1,8-cineole. (***p<0.001 and **p<0.01 was considered significant, unpaired t-
test, two tailed, confidence interval: 95%). Data merged from two independent 
measurements. (C-D) Amount of nuclear localized NF-κB p65 was significantly reduced in 
U373 cells after co-treatment with Poly(I:C) and 1,8-cineole in comparison to Poly(I:C)- 
stimulation for 2 h (immunocytochemical stainings displayed as intensity scale; ***p<0.001 
was considered significant, unpaired t-test, two tailed, confidence interval: 95%). 
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Figure 3. Inferior turbinate stem cells treated with Poly(I:C) show significantly increased 
IRF3-activity accompanied by significantly reduced NF-κB-activity after co-treatment with 1,8-
cineole. (A) Schematic view of the nasal cavity. (B) Isolated ITSCs cultivated as 
characteristic free-floating spheres and in an adherent state. (C) ITSCs expressed TLR3 and 
TLR4, relevant receptors of Poly(I:C)- and LPS-recognition. (D-E) Compared to control, 
Poly(I:C)-treatment of ITSCs for 2 h resulted in significantly increased nuclear translocation 
of IRF3 accompanied by significantly elevated amounts of nuclear localized NF-κB p65. Co-
treatment with Poly(I:C) and 1,8-cineole led to further significantly increased nuclear 
translocation of IRF3 and significantly decreased amounts of nuclear localized NF-κB p65 in 
comparison to Poly(I:C)-stimulation. Immunocytochemical stainings are displayed as 
intensity scale; (***p<0.001, **p<0.01 and *p<0.05 was considered significant, unpaired t-
test, two tailed, confidence interval: 95%). 
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Figure 4. 1,8-cineole leads to significantly decreased activity of NF-κB in LPS-treated ITSCs 
and highly elevated expression of the IRF3 target gene RANTES in a model of 
superinfection. (A-B) LPS-treatment of ITSCs for 2 h led to a significantly elevated nuclear 
translocation of NF-κB p65, which was significantly decreased after co-treatment with 1,8-
cineole. Immunocytochemical staining displayed as intensity scale. (C) Real time PCR 
depicting significantly increased expression levels of the IRF3 target gene RANTES in ITSCs 
pre-treated with Poly (I:C) for 4 h followed by co-exposure to Poly(I:C) and LPS for 20 h in 
comparison to control. Co-treatment of ITSCs with Poly(I:C)/LPS and 1,8-cineole after 
Poly(I:C) pre-treatment resulted further elevated expression levels of RANTES. n.d.: not 
detectable. (***p<0.001 and **p<0.01 was considered significant, unpaired t-test, two tailed, 
confidence interval: 95%). 
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Figure 5. Ex vivo cultivated human nasal turbinate tissue stimulated with Poly(I:C) shows a 
significantly increased amount of nuclear IRF3 after co-treatment with 1,8-cineole. (A) 
Immunohistochemical stainings (displayed as intensity scale) of human nasal turbinate slice 
cultures showed increased amounts of nuclear localized IRF3 after 2 h of Poly(I:C)-treatment 
in comparison to untreated control, which was further increased after co-treatment with 1,8-
cineole. (B) Quantification of nuclear fluorescence intensities of immunohistochemical 
stainings revealed significantly increased nuclear localization of IRF3 after co-treatment with 
Poly(I:C) and 1,8-cineole for 2 h in comparison to Poly(I:C)-treated approach and control. 
(***p<0.001 was considered significant, unpaired t-test, two tailed, confidence interval: 95%)  
(C) Increased nuclear translocation of IRF3 in Poly(I:C)-treated nasal slice cultures after 4 h  
was further increased after co-treatment with 1,8-cineole. (D) Quantification of nuclear 
fluorescence intensities of immunohistochemical stainings showed significantly increased 
nuclear localization of IRF3 after 4 h of Poly(I:C)-treatment and co-treatment with Poly(I:C) 
and 1,8-cineole compared to control (***p<0.001 was considered significant, unpaired t-test, 
two tailed, confidence interval: 95%). 
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Figure 6. 1,8-cineole leads to a reduction in nuclear localized NF-κB of ex vivo cultivated 
human nasal turbinate slices after Poly(I:C)-dependent stimulation. (A) Immunohistochemical 
stainings (displayed as intensity scale) of human nasal turbinate slice cultures showed 
increased nuclear translocation of NF-κB p65 in Poly(I:C)-treated nasal slice cultures 
compared to control after 2h. Co-treatment with Poly(I:C) and 1,8-cineole for 2 h resulted in 
highly decreased NF-κB-activity. (B) Quantification of nuclear fluorescence intensities of 
immunohistochemical stainings revealed significantly increased nuclear localization of NF-κB 
p65 after 2 h of Poly(I:C)-treatment, which was significantly decreased after co-treatment 
with 1,8-cineole (***p<0.001 was considered significant, unpaired t-test, two tailed, 
confidence interval: 95%). 
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Figure 7. Ex vivo-cultivated human nasal turbinate slices stimulated with LPS show 
increased IRF3-activity and decreased NF-κB activity after co-treatment with 1,8-cineole. (A) 
Immunohistochemical analysis (displayed as intensity scale) of human nasal slice cultures 
depicting increased fluorescence intensity of IRF3 and NF-κB p65 after LPS-treatment in 
comparison to control. Co-treatment with LPS and 1,8-cineole resulted in increased nuclear  
fluorescence intensity of IRF3 as well as decreased NF-κB p65 nuclear fluorescence 
intensity compared to LPS-stimulated approach. (B-C) Quantification of nuclear fluorescence 
intensity of cells in the epithelial layer of cultured human nasal turbinates showed 
significantly increased nuclear localization of IRF3 and NF-κB p65 after LPS-treatment 
compared to control. Nuclear localization of IRF3 was significantly increased after co-
treatment with LPS and 1,8-cineole in comparison to control, while the amount of nuclear 
localized NF-κB p65 was significantly decreased in comparison to the LPS-approach. 
(***p<0.001, unpaired t-test, two tailed, confidence interval: 95%). 
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Supplementary figures 
 
Figure S1. Poly(I:C) leads to increased nuclear localization of IRF3. Immunocytochemical 
stainings (see also Fig. 1C) not depicted as intensity scale showed nuclear localization of 
IRF3 by overlay with the DNA-counterstaining. In comparison to untreated controls (A), 
Poly(I:C)-treatment for 4 h led to increased nuclear localization of IRF3 in U251 cells (B). 
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Figure S2. Poly(I:C) leads to increased nuclear localization of NF-κB p65. 
Immunocytochemical stainings (see also Fig. 1C) not depicted as intensity scale showed 
nuclear localization of NF-κB p65 by overlay with the DNA-counterstaining. In comparison to 
untreated controls (A), Poly(I:C)-treatment for 2 h led to increased nuclear localization of NF-
κB p65 in U251 cells (B). 
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Figure S3. 1,8-cineole alone does not lead to altered IRF3- and NF-κB-activity in U373 cells 
and ITSCs. (A) Luciferase activity in U373 cells transiently transfected with IRF3-GAL4 and 
UAS-LUC vectors was not increased after treatment with 1,8-cineole in comparison to 
untreated control. (B) Amount of nuclear localized NF-κB p65 was not reduced in U373 cells 
after treatment with 1,8-cineole in comparison to control. (C) ITSCs showed no changes of 
nuclear translocation of IRF3 and NF-κB after treatment with 1,8-cineole for 4 h in 
comparison to control. 
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Figure S4. LPS-dependent nuclear localization of NF-κB p65 in the epithelial layer of ex vivo 
cultivated human nasal turbinate slices is strongly attenuated after exposure to 1,8-cineole. 
(A) Immunohistochemical stainings of cultivated human nasal turbinate tissue revealed 
CK14-positive intact epithelial layer showing increased nuclear translocation of NF-κB p65 
after LPS-treatment, which was reduced after co-treatment with 1,8-cineole. (B-C) 
Quantification of fluorescence intensities of the immunohistochemical stainings revealed a 
significant increase in the amount of nuclear localized NF-κB p65 in the whole epithelial layer 
and specifically in ciliated as well as in basal cells after LPS-treatment, which was 
significantly decreased after co-treatment with 1,8-cineole (***p<0.001, unpaired t-test, two 
tailed, confidence interval: 95%). 
